Insider · CIK 0001563623
Andrew Gengos
cfoofficer
Files at TERN (Terns Pharmaceuticals, Inc.). First filing Jun 16, 2025, latest Jun 30, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$96k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Terns Pharmaceuticals, Inc. | $39k 10,000 shares | +67% | - | |
| 45Moderate | Terns Pharmaceuticals, Inc. | $57k 15,000 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | TERN Terns Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +5,000 | $3.93 | $20k | 20,000 | Jun 30, 2025 |
| Jun 27, 2025 | TERN Terns Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +5,000 | $3.93 | $20k | 25,000 | Jun 30, 2025 |
| Jun 13, 2025 | TERN Terns Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +5,000 | $3.75 | $19k | 5,000 | Jun 16, 2025 |
| Jun 13, 2025 | TERN Terns Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +5,000 | $3.72 | $19k | 10,000 | Jun 16, 2025 |
| Jun 16, 2025 | TERN Terns Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +5,000 | $3.95 | $20k | 15,000 | Jun 16, 2025 |
| Feb 24, 2025 | TERN Terns Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +750,000 | $0.00 | $0 | 750,000 | Feb 25, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.